Adherence to treatment in systemic lupus erythematosus patients

Best Practice and Research: Clinical Rheumatology

Volumn 27, Issue 3, 2013, Pages 329-340

  Costedoat Chalumeau, Nathalie ^a,b   Pouchot, Jacques ^a,c   Guettrot Imbert, Gaëlle ^d,e   Le Guern, Véronique ^b   Leroux, Gaëlle ^f   Marra, Donata ^f   Morel, Nathalie ^b   Piette, Jean Charles ^f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin ^*  (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adherence; Compliance; Flare; Hydroxychloroquine; Systemic lupus erythematosus; Therapeutic drug monitoring

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACADEMIC ACHIEVEMENT; ARTICLE; DEPRESSION; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; MEDICATION COMPLIANCE; MORBIDITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; POLYPHARMACY; PRIORITY JOURNAL; RISK FACTOR; SOCIAL CLASS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT REFUSAL;

ADHERENCE; COMPLIANCE; FLARE; HYDROXYCHLOROQUINE; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPEUTIC DRUG MONITORING;

ANTIRHEUMATIC AGENTS; ATTITUDE TO HEALTH; BIOLOGICAL MARKERS; DRUG MONITORING; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICATION ADHERENCE;

EID: 85027935429     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2013.07.001     Document Type: Review

References (50)

1. S.V. Navarra, R.M. Guzman, and A.E. Gallacher Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Lancet 377 2011 721 731
2. L. Osterberg, and T. Blaschke Drug therapy: adherence to medication New England Journal of Medicine 353 2005 487 497
3. R.B. Haynes, K.A. McKibbon, and R. Kanani Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications Lancet 348 1996 383 386
4. N.H. Miller, M. Hill, T. Kottke, and I.S. Ockene The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals Circulation 95 1997 1085 1090
5. K.C. Farmer Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice Clinical Therapeutics 21 1999 1074 1090 discussion 1073
6. J.A. Cramer, R.D. Scheyer, and R.H. Mattson Compliance declines between clinic visits Archives of Internal Medicine 150 1990 1509 1510
7. J.S. Benner, R.J. Glynn, and H. Mogun Long-term persistence in use of statin therapy in elderly patients Journal of the American Medical Association 288 2002 455 461
8. J. Yeaw, J.S. Benner, and J.G. Walt Comparing adherence and persistence across 6 chronic medication classes Journal of Managed Care Pharmacy 15 2009 728 740
9. M. Petri, S. Perez-Gutthann, J.C. Longenecker, and M. Hochberg Morbidity of systemic lupus erythematosus: role of race and socioeconomic status American Journal of Medicine 91 1991 345 353
10. A.G. Uribe, G.S. Alarcon, and M.L. Sanchez Systemic lupus erythematosus in three ethnic groups. XVIII. Factors predictive of poor compliance with study visits Arthritis & Rheumatism 51 2004 258 263
11. A. Mosley-Williams, M.A. Lumley, and M. Gillis Barriers to treatment adherence among African American and white women with systemic lupus erythematosus Arthritis & Rheumatism 47 2002 630 638
12. J. Mirotznik, E. Ginzler, G. Zagon, and A. Baptiste Using the health belief model to explain clinic appointment-keeping for the management of a chronic disease condition Journal of Community Health 23 1998 195 210
13. D.D. Gladman, D.R. Koh, M.B. Urowitz, and V.T. Farewell Lost-to-follow-up study in systemic lupus erythematosus (SLE) Lupus 9 2000 363 367
14. J. Rojas-Serrano, and M.H. Cardiel Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study Lupus 9 2000 601 606
15. M. Oliveira-Santos, J.F. Verani, E.M. Klumb, and E.M. Albuquerque Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil Lupus 20 2011 320 329
16. I. Duvdevany, M. Cohen, A. Minsker-Valtzer, and M. Lorber Psychological correlates of adherence to self-care, disease activity and functioning in persons with systemic lupus erythematosus Lupus 20 2011 14 22
17. S. Koneru, M. Shishov, and A. Ware Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting Arthritis & Rheumatism 57 2007 1000 1006
18. T.V. Ting, D. Kudalkar, and S. Nelson Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus Journal of Rheumatology 39 2012 174 179
19. S.A. Chambers, R. Raine, A. Rahman, and D. Isenberg Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort Rheumatology (Oxford) 48 2009 266 271
20. M.F. Marengo, C.A. Waimann, and S. de Achaval Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring Lupus 21 2012 1158 1165
21. N. Costedoat-Chalumeau, Z. Amoura, and J.S. Hulot Very low blood hydroxychloroquine concentrations as an objective marker of poor adherence to treatment in systemic lupus erythematosus Annals of the Rheumatic Diseases 66 2007 821 824
22. I.N. Bruce, D.D. Gladman, and M.B. Urowitz Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence Arthritis Care & Research 13 2000 406 408
23. L. Sailler, B. Puissant, and P. Meliani Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients Annals of the New York Academy of Sciences 1108 2007 41 50
24. M.M. Ward, D.S. Lotstein, and T.M. Bush Psychosocial correlates of morbidity in women with systemic lupus erythematosus Journal of Rheumatology 26 1999 2153 2158
25. L.J. Julian, E. Yelin, and J. Yazdany Depression, medication adherence, and service utilization in systemic lupus erythematosus Arthritis & Rheumatism 61 2009 240 246
26. G.M. Daleboudt, E. Broadbent, F. McQueen, and A.A. Kaptein Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus Arthritis Care & Research (Hoboken) 63 2011 342 350
27. A. Garcia-Gonzalez, M. Richardson, and M. Garcia Popa-Lisseanu Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus Clinical Rheumatology 27 2008 883 889
28. J.Y. Lee, S. Luc, and D.J. Greenblatt Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important Lupus 22 2013 541 542
29. N. Costedoat-Chalumeau, Z. Amoura, and J.S. Hulot Hydroxychloroquine in systemic lupus erythematosus Lancet 369 2007 1257 1258
30. G. Ruiz-Irastorza, M. Ramos-Casals, P. Brito-Zeron, and M.A. Khamashta Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review Annals of the Rheumatic Diseases 69 2010 20 28
31. T. Munster, J.P. Gibbs, and D. Shen Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis Arthritis & Rheumatism 46 2002 1460 1469
32. S.E. Tett, D.J. Cutler, C. Beck, and R.O. Day Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis-a prospective, dose ranging study Journal of Rheumatology 27 2000 1656 1660
33. S.E. Tett, R.O. Day, and D.J. Cutler Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis-a cross sectional study Journal of Rheumatology 20 1993 1874 1879
34. N. Costedoat-Chalumeau, L. Galicier, and O. Aumaitre Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study) Annals of the Rheumatic Diseases 2013; Jan 7 [Epub ahead of print]
35. S.E. Tett, D.J. Cutler, and R.O. Day Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques Journal of Pharmaceutical Sciences 81 1992 155 159
36. S.E. Tett, D.J. Cutler, R.O. Day, and K.F. Brown Bioavailability of hydroxychloroquine tablets in healthy volunteers British Journal of Clinical Pharmacology 27 1989 771 779
37. C. Frances, A. Cosnes, and P. Duhaut Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study Archives of Dermatology 148 2012 479 484
38. N. Costedoat-Chalumeau, Z. Amoura, and J.S. Hulot Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus Arthritis & Rheumatism 54 2006 3284 3290
39. P. Rudd, and L. Lenert Pharmacokinetics as an aid to optimising compliance with medications Clinical Pharmacokinetics 28 1995 1 6
40. R. Dusing, K. Lottermoser, and T. Mengden Compliance with drug therapy-new answers to an old question Nephrology Dialysis Transplantation 16 2001 1317 1321
41. WHO Adherence to long-term therapies: evidence for action 2003 wwwwhoint/chp/knowledge/publications/adherence-full-reportpdf
42. R.B. Haynes, E. Ackloo, and N. Sahota Interventions for enhancing medication adherence Cochrane Database of Systematic Reviews 2008 CD000011
43. M. Adler, S. Chambers, and C. Edwards An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period Rheumatology (Oxford) 45 2006 1144 1147
44. S. de Achaval, and M.E. Suarez-Almazor Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus International Journal of Clinical Rheumatology 5 2010 313 326
45. A.S. Kesselheim, A.S. Misono, and W.H. Shrank Variations in pill appearance of antiepileptic drugs and the risk of nonadherence Archives of Internal Medicine 2012 1 7
46. E. Lehane, and G. McCarthy Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper International Journal of Nursing Studies 44 2007 1468 1477
47. M.G. Garcia Popa-Lisseanu, A. Greisinger, and M. Richardson Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease Journal of Rheumatology 32 2005 913 919
48. S. Chambers, R. Raine, and A. Rahman Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica Lupus 17 2008 761 769
49. R.B. Haynes, X. Yao, and A. Degani Interventions to enhance medication adherence Cochrane Database of Systematic Reviews 2005 CD000011
50. E. de Klerk, D. van der Heijde, and R. Landewe Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout Journal of Rheumatology 30 2003 44 54